This is the second webinar in the BioMedical SIG webinar series, “From Research to Development – Paths to Cross the Valley of Death in Life Sciences”, which showcases initiatives available to European KTOs to maturate technologies with potential in TRL and CRL, without the creation of a spin-off.
In this session, speakers Peter Nussbaumer and Gernot Faustmann will present the KHAN/w4i/LDC initiative. This collaborative drug discovery platform facilitates the translation of world-class science into innovative therapies for the benefit of patients. Their mission is to create value through cooperative drug development partnerships with academic innovators in Europe. They focus on first-in-class therapies for attractive markets with a high unmet medical need.
This webinar is organised by the BioMedical SIG and supported by UCB. Join the BioMedical SIG to stay informed.
I learned more in the training course for 3 days than I did in the last 3 months at my job. The lectures were informative & interesting.
Hanna Sonnig
Setterwalls Advokatbyrå, Sweden
The course Software Specific Challenges is a must for every TTO/KTO professional, especially for those working with Social Sciences and Humanities!
Brechtje Vreenegoor
Radboud University, Netherlands
The software training filled in the many blanks and brought my 'fractioned' knowledge in a structured way. Very useful!
Ilse Sienaert
KU Leuven R&D, Belgium
I strongly recommend the course, even if you are not going to set-up an office but you are part of the team that wants to change or improve how technology transfer is done at your institution.
Ricardo Castro
Centre for research in agricultural Genomics, Spain
I am happy to be able to share my own experiences with other colleagues via various courses, and I enjoy every moment I can spend in this network. Proud to be part of the ASTP community!
Paul van Dun
KU Leuven, Belgium
Join our newsletter and get the latest news